Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 5, 1997, Pages 1515-1522

  Marie, Christelle ^b   Losser, Marie Reine ^b   Fitting, Catherine ^b   Kermarrec, Nathalie ^b   Payen, Didier ^b   Cavaillon, Jean Marc ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG LAVAGE; MALE; PLASMA; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; SEPSIS;

EID: 0030678513     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.5.9702108     Document Type: Article

References (35)

1. Bernard, G. R., A. Artigas, K. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. Legall, A. Morris, and R. Spragg. 1994. The American-European Consensus on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149:818-824.
2. Doyle, R., N. Szaflarski, G. Modin, J. Wiener-Kronish, and M. Matthay. 1995. Identification of patients with acute lung injury. Predictors of mortality. Am. J. Respir. Crit. Care Med. 152:1818-1824.
3. Guinard, N., S. Beloucif, C. Gatecel, J. Mateo, and D. Payen. 1997. Evaluation of therapeutic optimization strategy in severe ARDS. Chest 111:1000-1007.
4. Dehoux, M. S., A. Boutten, J. Ostinelli, N. Seta, M. C. Dombret, B. Crestani, M. Deschenes, J. L. Trouillet, and M. Aubier. 1994. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 150:710-716.
5. Chollet-Martin, S., C. Gatecel, N. Kermarrec, M. A. Gougerot-Pocidalo, and D. M. Payen. 1996. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am. J. Respir. Crit. Care Med. 153:985-990.
6. Donnelly, S., R. Strieter, S. Kunkel, A. Walz, C. Robertson, D. Carter, I. Grant, A. Pollock, and C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patients groups. Lancet 341:643-647.
7. Suter, P. M., S. Suter, E. Girardin, P. Roux-Lombard, G. E. Grau, and J. M. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145:1016-1022.
8. Haymann, D., E. L'Her, J. M. NGuyen, S. Raher, I. Canfrère, L. Coupey, P. Fixe, E. Chailleux, D. De Groote, V. Praloran, and A. Godard. 1996. Leukaemia inhibitory factor production in pleural effusions: comparison with production of IL-4, IL-8, IL-10 and M-CSF. Cytokine 8:410-416.
9. Broaddus, V. C., C. A. Hébert, R. V. Vitangcol, J. M. Hoeffel, M. S. Berstein, and A. M. Boylan. 1992. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am. Rev. Respir. Dis. 146:825-330.
10. Antony, V. B., S. W. Godey, S. L. Kunkel, J. W. Hott, D. L. Hartman, M. D. Burdick, and R. M. Strieter. 1993. Recruitment of inflammatory cells to pleural space: chemotactic cytokines, IL-8 and MCP-1 in human pleural fluids. J. Immunol. 151:7216-7223.
11. Antony, V. B., J. W. Hott, S. L. Kunkel, S. W. Godbey, M. D. Burdick, and R. M. Strieter. 1995. Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am. J. Respir. Cell Mol. Biol. 12:581-588.
12. Barnes, P. F., S. J. Fong, P. J. Brennan, P. E. Twomey, A. Mazumder, and R. L. Modlin. 1990. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J. Immunol. 145:149-154.
13. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482-3489.
14. Maeda, J., N. Ueki, T. Ohkawa, N. Iwahashi, T. Nakano, T. Hada, and K. Higashino. 1993. Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin. Exp. Immunol. 92: 32-38.
15. Zhang, M., M. K. Gately, E. Wang, J. Gong, S. F. Wolf, S. Lu, R. L. Modlin, and P. F. Barnes. 1994. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest. 93:1733-1739.
16. Silva-Mejias, C., F. Gamboa-Antiñolo, L. F. Lopez-Cortes, M. Cruz-Ruiz, and J. Pachon. 1995. Interleukin-1β in pleural fluids of different etiologies. Its role as inflammatory mediator in empyema. Chest 108: 942-945.
17. Monti, G., M. C. Jaurand, I. Monnet, P. Chretien, L. Saint-Etienne, L. Zeng, A. Portier, P. Deviller, P. Galanaud, J. Bignon, and D. Emilie. 1994. Intrapleural production of interleukin-6 during mesothelioma and its modulation by γ-interferon treatment. Cancer Res. 54:4419-4423.
18. Fujino, S., A. Yokoyama, N. Kohno, and K. Hiwada. 1996. Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 14:508-515.
19. Lanfrancome, L., D. Boraschi, P. Ghiara, B. Falini, F. Grignani, G. Peri, A. Mantovani, and P. G. Pelicci. 1992. Human peritoneal mesothelial cells produce many cytokines (G-CSF, GM-CSF, IL-1 and IL-6) and are activated and stimulated to grow by IL-1. Blood 80:2835-2842.
20. Chollet-Martin, S., P. Montravers, C. Gibert, C. Elbim, J. M. Desmonts, J. Y. Fagon, and M. A. Gougerot-Pocidalo. 1993. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect. Immun. 61:4553-4559.
21. Peters, M., S. Jacobs, M. Ehler, P. Vollmer, J. Müllerg, E. Wolf, G. Brem, K. H. Meyer, and S. Rose-John. 1996. The function of the soluble interleukin-6 receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183:1399-1406.
22. Rouby, J. J., E. Martin De Lassale, P. Poete, M. H. Nicolas, L. Bodin, V. Jarlier, Y. Le Charpentier, J. Grosset, and P. Viars. 1992. Nosocomial bronchopneumonia in the critically ill: histologic and bacteriologic aspects. Am. Rev. Respir. Dis. 146:1059-1066.
23. Light, R., M. McGregor, P. Luchsinger, and W. Ball. 1972. Pleural effusions: the diagnostic separation of transudates and exudates. Ann. Intern. Med. 77:507-513.
24. Ledur, A., C. Fitting, B. David, C. Hamberger, and J. M. Cavaillon. 1995. Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. J. Immunol. Methods 186:171-179.
25. Marty, C., B. Misset, F. Tamion, C. Fitting, J. Carlet, and J.-M. Cavaillon. 1994. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit. Care Med. 22:673-679.
26. Muñoz, C., B. Misset, C. Fitting, J. P. Bleriot, J. Carlet, and J. M. Cavaillon. 1991. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur. J. Immunol. 21:2177-2184.
27. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 89:4845-4849.
28. van der Poll, T., J. Jansen, D. van Leenen, M. von der Mohlen, M. Levi, H. ten Cate, H. Gallati, J. W. ten Cate, and S. J. van Deventer. 1993. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J. Infect. Dis. 168:955-960.
29. Fischer, E., K. J. Van Zee, M. A. Marano, C. S. Rock, J. S. Kenney, D. D. Poutsiaka, C. A. Dinarello, S. F. Lowry, and L. L. Moldawer. 1992. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196-2200.
30. Yanagawa, H., S. Yano, T. Haku, Y. Ohmoto, and S. Sone. 1996. Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease. Eur. Respir. J. 9:1211-1216.
31. Shimokata, K., H. Saka, T. Murate, Y. Hasegawa, and T. Hasegawa. 1991. Cytokine content in pleural effusion: comparison between tuberculosis and carcinomatous pleurisy. Chest 99:1103-1107.
32. Yokoyama, A., N. Kohno, S. Fujino, M. Abe, O. Ishida, and K. Hiwada. 1996. Soluble interleukin-6 receptor levels in pleural effusions. Respir. Med. 90:329-332.
33. Doré, P., E. Lelièvre, F. Morel, A. Brizard, M. Fourcin, C. Clément, P. Ingrand, L. Daneski, H. Gascan, J. Wijdenes, J. Gombert, J. L. Preudhomme, and J. C. Lecron. 1997. IL-6 soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions - massive IL-6 production independently of underlying diseases. Clin. Exp. Immunol. 107:182-188.
34. Negrini, D., D. Venturoli, M. I. Townsley, and R. K. Reed. 1994. Permeability of parietal pleura to liquid and proteins. J. Appl. Physiol. 76: 627-633.
35. Cavaillon, J. M., C. Muñoz, C. Fitting, B. Misset, and J. Carlet. 1992. Circulating cytokines: the tip of the iceberg? Circ. Shock 38:145-152.